Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,700,834
+$285,845 QoQ
Shares Held
6,759
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#2,098
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Management Associates, Inc. holds $14,108,701 across 10 Drug Manufacturers - General names. ABBV ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,266 | $3,369,166 | |
| 2 | LLY |
ELI LILLY & Co
|
2,744 | $3,291,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,581 | $2,002,158 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,759 | $1,700,834 | |
| 5 | PFE |
Pfizer Inc
|
63,133 | $1,520,242 | |
| 6 | AMGN |
Amgen Inc
|
3,099 | $1,122,209 | |
| 7 | AZN |
Astrazeneca PLC
|
1,780 | $337,523 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,535 | $320,271 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,700,834 | 6,759 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,414,989 | 6,506 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,485,413 | 6,501 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,504,083 | 6,496 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,204,859 | 6,491 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,470,620 | 7,019 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $1,246,210 | 7,013 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $1,366,956 | 6,922 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $1,186,403 | 6,917 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $1,259,585 | 6,917 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $1,126,631 | 7,270 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $1,138,818 | 7,640 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $1,086,058 | 8,061 | Shares | Sole | 2025-05-28 | |
| 2023-03-31 | $1,289,462 | 8,091 | Shares | Sole | 2025-05-28 | |
| 2022-12-31 | $1,318,252 | 8,157 | Shares | Sole | 2025-05-28 | |
| 2022-09-30 | $1,249,092 | 9,307 | Shares | Sole | 2025-05-28 | |
| 2022-06-30 | $1,424,081 | 9,298 | Shares | Sole | 2025-05-28 | |
| 2022-03-31 | $1,042,691 | 6,432 | Shares | Sole | 2025-05-28 | |
| 2021-12-31 | $813,483 | 6,008 | Shares | Sole | 2025-05-28 | |
| 2021-09-30 | $539,889 | 5,005 | Shares | Sole | 2025-05-28 | |
| 2021-06-30 | $412,825 | 3,665 | Shares | Sole | 2025-05-28 | |
| 2021-03-31 | $392,838 | 3,630 | Shares | Sole | 2025-05-28 | |
| 2020-12-31 | $357,559 | 3,337 | Shares | Sole | 2025-05-28 | |
| 2020-09-30 | $294,214 | 3,359 | Shares | Sole | 2025-05-28 | |
| 2020-06-30 | $320,557 | 3,265 | Shares | Sole | 2025-05-28 | |
| 2020-03-31 | $211,960 | 2,782 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||